Life Sciences & Biotechnology
Research Agricultural
Total number of Record(s): 4180
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Understanding the role of SARS-CoV-2 virulence factor-Orf3a in modulating host cell responses: A way to identify host-directed therapy | Dr Amit Tuli, Scientist, CSIR-Institute of Microbial Technology, Chandigarh | 2020 | Department of Science and Technology (DST), Govt of India | Therapeutics for COVID-19 |
| Targeting the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 for the development of inhibitors | Prof Benu Brata Das, Indian Association for the Cultivation of Science (IACS), Kolkata | 2020 | Department of Science and Technology (DST), Govt of India | Therapeutics for COVID-19 |
| Development of a point-of-care fibre-optic biosensor (P-FAB) device for rapid detection of COVID-19 | Dr Raghavendra Sai V, Associate Professor, Indian Institute of Technology (IIT) Madras | 2020 | Department of Science and Technology (DST), Govt of India | COVID-19 Diagnostics |
| An easy and rapid detection platform for viral diseases from saliva: COVID-19 and beyond | Dr Jayasree RS, Scientist, Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST), Thiruvananthapuram | 2020 | Department of Science and Technology (DST), Govt of India | COVID-19 Diagnostics |
| Development of machine learning-based drug repurposing pipeline against SARS-CoV-2 and human proteome | Dr Kamal Rawal, Associate Professor, Amity University, Uttar Pradesh | 2020 | Department of Science and Technology (DST), Govt of India | COVID-19 Therapeutics |
| Rapid, PCR or antibody-free clinical diagnosis of viral infection via ‘chemical-nose’ sensor | Dr Mrinmoy De, Assistant Professor, Indian Institute of Science (IISC), Bengaluru | 2020 | Department of Science and Technology (DST), Govt of India | COVID-19 Diagnostics |
| A phase II B open label randomised controlled trial to evaluate the efficacy and safety of Ivermectin in reducing viral loads in patients with hematological disorders who are admitted with COVID-19 infection (ICE study) | Dr Biju George, Professor, Christian Medical College (CMC), Vellore | 2020 | Department of Science and Technology (DST), Govt of India | COVID-19 Therapeutics |
| In silico analysis of 10000 genomic sequences of COVID-19 around the world including India to identify genetic variability and potential molecular targets in virus and human | Dr Indrajit Saha, Assistant Professor, National Institute of Technical Teachers Training and Research (NITTTR), Kolkata | 2020 | Department of Science and Technology (DST), Govt of India | Genome sequencing for COVID-19 |
| Nanopore sequencing-based rapid monitoring of Covid-19 nucleic acids in the drains of Pune river | Dr Mahesh S Dharne, Scientist, CSIR-National Chemical Laboratory (NCL), Pune | 2020 | Department of Science and Technology (DST), Govt of India | COVID-19 Management |
| A randomised controlled trial of single-dose oral Ivermectin in patients with COVID-19 infection | Dr Anant Mohan, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2020 | Department of Science and Technology (DST), Govt of India | COVID-19 Therapeutics |